The Prescription Medicines Code of Practice Authority (PMCPA) has recently published new social media guidance to help pharma companies apply the high standards demanded by the industry's C
Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time.
The UK’s pharmaceutical industry has published headline figures from its Disclosure UK scheme, showing payments from pharma to healthcare professionals increased in 2019.
Sarepta Therapeutics has decided not to continue the development of vesleteplirsen, a follow-up to its Duchenne muscular dystrophy (DMD) therapy Exondys 51.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.